Form 4 for HCAT Health Catalyst, Inc.
Accepted 2022-04-29 00:00:00 ET · period of report 2022-04-27 · accession 0001562180-22-003579 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-29 | 2022-04-27 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +5,000 | 107.7K | +5% | +$51.7K |
| D | 2022-04-29 | 2022-04-27 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $0.00 | -5,000 | 53.3K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-27 | M | A | 5,000 | $10.34 | 107,733 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-04-27 | M | D | 5,000 | $0.00 | 53,270 | D | $10.34 · 2019-12-31 to 2026-02-10 | 5,000 Common Stock | (F1) 25% of the shares vested on December 31, 2016 and the remaining 75% vested in 36 equal monthly installments thereafter until the option was vested in full on Dec. 31, 2019. |